Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
QUEEN-IVF
2024-511190-30-00Phase 2Authorised
- Sponsor
- Amsterdam University Medical Center
- Start
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of quinidine and verapamil in idiopathic ventricular fibrillation (IVF) (2 arms), sponsored by Amsterdam University Medical Center. Planned start Feb 2024; status: authorised.
02
Drugs
quinidineverapamil
03
Conditions
idiopathic ventricular fibrillation (IVF)
Beyond the preview
Go deeper on 2024-511190-30-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-511190-30-00.